(Q37277087)

19 August 2017

1 reference

title

Antibiotic-associated diarrhea: epidemiology, trends and treatment (English)

1 reference

19 August 2017

0 references

1 reference

Lynne V McFarland

1

1 reference

19 August 2017

1 October 2008

1 reference

19 August 2017

16

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

19 August 2017

3

1 reference

19 August 2017

5

1 reference

19 August 2017

563-578

1 reference

Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study

19 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

A systematic review and meta-analysis of misuse of antibiotic therapies in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Implications of the changing face of Clostridium difficile disease for health care practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Update on the changing epidemiology of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Annual incidence of MRSA falls in England, but C difficile continues to rise

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Recent advances in Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Antibiotic-associated diarrhea in a Turkish outpatient population: investigation of 288 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Recommendations for surveillance of Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Pseudomembranous colitis: causes and cures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Who are susceptible to pseudomembranous colitis among patients with presumed antibiotic-associated diarrhea?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Risk factors for early recurrent Clostridium difficile-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Risk factors for Clostridium difficile colonisation and toxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

The burden of Clostridium difficile in surgical patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Probiotics, gut inflammation and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Adverse effects of newer cephalosporins. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Revised nomenclature of Clostridium difficile toxins and associated genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Amoxicillin-associated hemorrhagic colitis in the presence of Klebsiella oxytoca

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Do infection control measures work for methicillin-resistant Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Role of Candida in antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Evidence for neuromodulation of enteropathogen invasion in the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Antimicrobial-associated risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Recurrent clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Treatment of Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

The importance of guidelines in the development and application of probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Management of an outbreak of Clostridium difficile-associated disease among geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Clostridium difficile–associated Diarrhea in Heart Transplant Recipients: Is Hypogammaglobulinemia the Answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.5.563

21 January 2018

Identifiers

DOI

10.2217/17460913.3.5.563

1 reference

19 August 2017

1 reference

PubMed ID

18811240